AFTER going through a sustained phase of accumulation, following the announcement of the movement control order (MCO), pharmaceutical stocks saw a sudden surge in prices during the week.
They have seen strong gains after traders and investors drove up their prices in expectations of a Covid-19 vaccine that would be available in the near future.
However, in the latter part of the week, their share prices fell, but still closed higher than when they were before the week began.
...